Infection site | 2018 | 2019 | 2020 | χ2 | P |
---|---|---|---|---|---|
Lower respiratory tract | 49.83% | 52.65% | 43.06% | 44.024 | < 0.001 |
Urinary system | 18.41% | 18.72% | 26.94% | 59.748 | < 0.001 |
Abdomen and digestive system | 8.16% | 11.83% | 11.81% | 18.153 | < 0.001 |
Skin and soft tissue | 6.73% | 5.37% | 7.27% | 7.446 | 0.024 |
Blood system | 6.12% | 4.73% | 4.44% | 6.526 | 0.038 |
Surgical site | 1.98% | 1.48% | 0.74% | 11.586 | 0.003 |
Eye/ear/nose/throat/mouth | 1.93% | 0.76% | 1.02% | 13.013 | 0.001 |
Upper respiratory tract | 1.21% | 0.92% | 0.83% | 1.585 | 0.453 |
Central nervous system | 0.94% | 1.24% | 0.60% | 5.094 | 0.078 |
Bone and joint | 0.55% | 0.16% | 0.37% | 4.821 | 0.090 |
Genital tract | 0.55% | 0.44% | 0.19% | 3.745 | 0.154 |
Otitis externa, otitis media | 0.50% | 0 | 0 | – | – |
Cardiovascular system | 0.33% | 0.36% | 0.42% | 0.208 | 0.901 |
Other sites | 2.76% | 1.32% | 2.31% | 11.768 | 0.003 |